A little-known biotech firm focused on Traditional Chinese Medicine has surged over 64,000%, catapulting its valuation to nearly $10 billion. Is this a biotech breakthrough, a speculative frenzy, or something in between?
Join Dan Koh and Ryan Huang as they dissect the rise of Regencell Bioscience Holdings Limited — a company with just 12 employees, no FDA-approved products, and a CEO earning $1 a year.

Unusual Jobs: Can you make a living as a Professional Wrestler in Singapore?
32:39

Breakfast Bites: How would you deal with noisy neighbours?
13:40

The Final Score: Who will win the Singapore Grand Prix… and the Liverpool-Manchester City blockbuster?
11:49